ARS Pharmaceuticals Raises $55M in Series D Funding

02 Sep, 2021

ARS Pharmaceuticals Raises $55M in Series D Funding
Photo by Todd Gardner on Unsplash

– ARS Pharmaceuticals, a San Diego CA-based pharmaceutical company, raised $55M in Series D funding.
– The round was led by SR One with participation from RA Capital Management and Deerfield Management.
– The company intends to use the funds to advance Neffy through approval, to support initial launch activities, and to evaluate it in clinical studies for additional indications.

Biopharma Health Care Medical North America Pharmaceutical
Crunchbase icon

Content report

The following text will be sent to our editors: